ALPS GROUP INC
ALPSNASDAQTrading Snapshot
- Day Range
- $0.39 β $0.40
- 52-Week Range
- $0.23 β $12.01
- Volume
- $3.27B
- Avg Volume
- $3.30B
- Shares Outstanding
- 166.4M
- Next Earnings
- Nov 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $5M
- Last Q Revenue
- $1M
- P/E Ratio
- -0.4
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-0.94
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β36.5%
Why Investors Own ALPS
- βHigh-growth profile β revenue up -7.4% YoY with expanding US Equity exposure.
- βHealthy economics β 26% gross margin and 13% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ALPS GROUP INC
ALPSAbout ALPS GROUP INC
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

ALPS Corporation Goes Live on OneShield Market Solutions to Power Lawyers' Professional Liability Operations for LawyerCare
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #AI--OneShield, a provider of modern, AI powered systems for commercial property & specialty insurers and MGAs, today announced that ALPS Property & Casualty Insurance Company (ALPS)

Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products

ALPS Ties Fund Growth to Distribution Discipline
Running a $22 billion ETF lineup with a distribution team far smaller than the largest issuers means every new fund has to earn its place on the shelf. Key Takeaways: A lean distribution team requires deliberate choices